Welcome

Close

What We Do

Who We Help

Who We Are

Browse by Category

Inpatient Clinical Care

Ambulatory & Post Acute Care

Global

RevenueCycle Financial / HIM

Value Based Care

Security & Privacy

Services & Consulting

Imaging Systems

Payer Solutions

Trending Vendors

Back

Back

2023 Best In Klas

Acute Care EMR (Global)

Latin America

REAL-TIME DATA

DECISION INSIGHTS

2023 Best In KLAS Acute Care EMR (Global) Latin America

Acute Care EMR (Global)
Latin America

Best in KLAS Winner

78.7
Overall Performance Score

REAL-TIME DATA

DECISION INSIGHTS

Ranked Solutions
Category average: 73.0
Software average: 80.3

Grading Scale

Company/solution	Overall performance score (100-point scale)	Total evaluations	Trend (2022-2023)	Culture	Loyalty	Operations	Product	Relationship	Value

Philips Philips Tasy (Non-US)	78.7	n=18	+4%	C	B	B-	B	C+	C-

MV SOUL (Non-US) (Mostly Brazil)	70.5	n=21	-3%	F	B-	C+	C+	D+	D-

Oracle Health (Cerner) i.s.h.med (Non-US)	60.1	n=6	-18%	F	D-	D+	C-	C-	F
	50.0	100.0

Company/solution	Trend (2022-2023)	Culture	Loyalty	Operations	Product	Relationship	Value

Philips Philips Tasy (Non-US) 78.7 n=18 COMMENTS	+4%	C	B	B-	B	C+	C-
MV SOUL (Non-US) (Mostly Brazil) 70.5 n=21 COMMENTS	-3%	F	B-	C+	C+	D+	D-
Oracle Health (Cerner) i.s.h.med (Non-US) 60.1 n=6 COMMENTS	-18%	F	D-	D+	C-	C-	F

Company/solution

Philips
Philips Tasy (Non-US)

78.7

n=18

Censinet assessment N/A

culture

C

loyalty

B

operations

B-

product

B

relationship

C+

value

C-

MV
SOUL (Non-US) (Mostly Brazil)

70.5

n=21

Censinet assessment N/A

culture

F

loyalty

B-

operations

C+

product

C+

relationship

D+

value

D-

Oracle Health
(Cerner) i.s.h.med (Non-US)

60.1

n=6

Censinet assessment N/A

culture

F

loyalty

D-

operations

D+

product

C-

relationship

C-

value

F

SolutionsNotRanked_Symbol

Solutions Not Ranked

L

Company/solution	Overall performance score (100-point scale)	Total evaluations	Culture	Loyalty	Operations	Product	Relationship	Value

Dedalus MedView (Non-US) (Brazil Only)	62	n=6	D	D-	C-	F	C-	D-

Dedalus xHIS (Non-US) (DXC Technology) * L	55.2	n=3	F	D-	F	F	F	D

InterSystems TrakCare EPR (Non-US)	80.3	n=12	B	B+	C+	C+	B-	C

NTT DATA ehCOS Clinic (Non-US) * L	66.9	n=3	D-	D-	C	C	C	D+

Oracle Health (Cerner) Millennium PowerChart (Non-US) * L	73.8	n=3	B-	B	C+	C-	C+	F

Pixeon SmartHealth (Non-US) (Brazil Only)	78.1	n=10	B-	C+	C	B	B-	C

L

Company/solution	Overall performance score (100-point scale)	Total evaluations

Dedalus MedView (Non-US) (Brazil Only) culture D loyalty D- operations C- product F relationship C- value D-	62	n=6

Dedalus xHIS (Non-US) (DXC Technology) * L culture F loyalty D- operations F product F relationship F value D	55.2	n=3

InterSystems TrakCare EPR (Non-US) culture B loyalty B+ operations C+ product C+ relationship B- value C	80.3	n=12

NTT DATA ehCOS Clinic (Non-US) * L culture D- loyalty D- operations C product C relationship C value D+	66.9	n=3

Oracle Health (Cerner) Millennium PowerChart (Non-US) * L culture B- loyalty B operations C+ product C- relationship C+ value F	73.8	n=3

Pixeon SmartHealth (Non-US) (Brazil Only) culture B- loyalty C+ operations C product B relationship B- value C	78.1	n=10

L

Company/solution

Dedalus
MedView (Non-US) (Brazil Only)

62
n=6

culture

D

loyalty

D-

operations

C-

product

F

relationship

C-

value

D-

Dedalus
xHIS (Non-US) (DXC Technology) * L

55.2
n=3

culture

F

loyalty

D-

operations

F

product

F

relationship

F

value

D

InterSystems
TrakCare EPR (Non-US)

80.3
n=12

culture

B

loyalty

B+

operations

C+

product

C+

relationship

B-

value

C

NTT DATA
ehCOS Clinic (Non-US) * L

66.9
n=3

culture

D-

loyalty

D-

operations

C

product

C

relationship

C

value

D+

Oracle Health
(Cerner) Millennium PowerChart (Non-US) * L

73.8
n=3

culture

B-

loyalty

B

operations

C+

product

C-

relationship

C+

value

F

Pixeon
SmartHealth (Non-US) (Brazil Only)

78.1
n=10

culture

B-

loyalty

C+

operations

C

product

B

relationship

B-

value

C

OtherNotablePerformances_Symbol

Other notable performances in Acute Care EMR (Global) (Latin America) Other notable performances

Solutions for which at least 95% of respondents answered yes.

Part of long-term plans?

Philips
Philips Tasy (Non-US)

n=18 100%

MV
MV SOUL (Non-US) (Mostly Brazil)

n=20 95%

Part of Long Term Plans?

Philips
Philips Tasy (Non-US)

n=18 100%

MV
MV SOUL (Non-US) (Mostly Brazil)

n=20 95%

Related Reports

View All Reports

Global (Non-US) EMR Market Share 2023

08 June 23 | Everton Santos and Jonathan Christensen

With the pandemic mostly past, healthcare organizations across the world are readdressing key technology priorities. EMR initiatives continue to be prioritized at most organizations. In 2022, KLAS validated 164 EMR purchase decisions impacting 532 hospitals and over 82,000 beds. 30 different vendors in 31 different countries were selected. While 2022 had the lowest validated EMR purchase activity of the last five years, certain markets remained highly active—specifically, Europe and Latin America and, to a lesser extent, Asia and the Middle East. Canada and Oceania, while relatively quiet in 2022, are poised for significant activity in 2023 due to major contracts on the horizon.

Global (Non-US) EMR Benefits 2023

16 March 23 | Everton Santos and Sidney Tate

As electronic medical record (EMR) adoption grows worldwide, healthcare organizations considering this digital transformation all have the same question: what benefits can we really expect to receive from implementing an EMR? KLAS interviewed leaders at 36 non-US healthcare organizations—12 of which are HIMSS Level 6 or 7—to learn about their journey to realizing benefits from an EMR implementation. This white paper summarizes their insights, including what clinical and operational benefits they have seen, when those benefits were realized, and what recommendations they have for peer organizations.

Asia/Oceania EMR 2022

21 December 22 | Everton Santos and Jonathan Christensen

As healthcare organizations have come out of the peak of the COVID-19 pandemic, EMR purchase decisions in Asia have ramped up. In Oceania, most public hospitals have an EMR in place, but purchase energy remains high since many public and private provider organizations are planning large-scale purchases of go-forward EMRs. This report—KLAS’ first focused exclusively on Asia and Oceania—highlights (1) market share and vendor energy in recent EMR purchase decisions and (2) vendor performance in each region based on client feedback and experience. The chart below offers a high-level view of vendors’ overall performance.

European EMR 2022

05 April 22 | Eder Lagemann and Sidney Tate

In the past few years, there has been significant merger and acquisition (M&A) activity among EMR vendors who market in Europe as well as significant purchasing activity by healthcare organizations, creating one of the world’s most dynamic EMR markets. From 2016–2020, KLAS validated over 300 EMR decisions impacting over 1,200 inpatient facilities (comprehensive data for 2021 purchases not yet available). Using this data and customer feedback from 100 organizations, this report examines the customer satisfaction, market share, and recent market energy of European EMR vendors and evaluates which are best meeting customer needs in this competitive market.

Middle East & Africa EMR 2021

09 September 21 | Everton Santos and Sidney Tate

Many healthcare organizations in the Middle East and some in Africa have made EMR purchase decisions over the last five years (2016–2020). In that time, KLAS has validated 86 EMR decisions—72 in the Middle East and 14 in Africa—impacting over 320 hospitals, with decisions made in 2018–2020 impacting (on average) at least twice as many facilities as decisions made in 2016–2017. This report will examine the customer satisfaction, market share, and recent wins and market energy of EMR vendors in the Middle East and Africa. Compared to KLAS’ previous report on EMRs in the Middle East (published in 2019), this study includes performance data on a significantly higher number of vendors, providing more expansive insights, particularly into the Middle East market.

Past Acute Care EMR (Global) Awards